This document discusses bio-medical waste management. It defines bio-medical waste and outlines the dangers of improper management, which can lead to public health hazards and environmental pollution. It describes the sources and categories of healthcare waste and how waste should be treated and disposed of according to regulations. Methods of treatment discussed include incineration, chemical disinfection, thermal treatment, and land disposal. The document also provides information on bio-medical waste management in India, including generation amounts, treatment facilities, and an example of a common treatment facility called IMAGE in Kerala.
JOINT DISEASE
A combination of pain and stiffness , leading to loss of function, is a classic feature of joint disease.Usually one component will predominates as stiffness in inflammation, and pain in mechanical joint problem.Therefore specific questions will establish whether symptoms are mechanical (e.g. degenerative joint disease & mechanical tear) or inflammatory(e.g. rheumatoid arthritis or gout).
JOINT DISEASE
A combination of pain and stiffness , leading to loss of function, is a classic feature of joint disease.Usually one component will predominates as stiffness in inflammation, and pain in mechanical joint problem.Therefore specific questions will establish whether symptoms are mechanical (e.g. degenerative joint disease & mechanical tear) or inflammatory(e.g. rheumatoid arthritis or gout).
Bioresource and waste management, utilizing biological resources, opting for various process for recycling them on to a large scale which can be a boon to society for human welfare.
Powerpoint presentation.
This is a ppt for safe diposal of waste. It basically talks about 4 methods:
-> Segregation of Waste
-> Dumping/Landfills
-> Composting of Wate
-> Drainage
It also provides the various methods and explanatory diagram
Indian Dental Academy: will be one of the most relevant and exciting training center with best faculty and flexible training programs for dental professionals who wish to advance in their dental practice,Offers certified courses in Dental implants,Orthodontics,Endodontics,Cosmetic Dentistry, Prosthetic Dentistry, Periodontics and General Dentistry.
Biomedical waste management and biohazards by Dr. Sonam AggarwalDr. Sonam Aggarwal
According to biomedical waste (management and Handling rules 1998 of India) –
"bio-medical waste" means any waste, which is generated during the diagnosis, treatment or immunization of human beings or animals or research activities pertaining thereto or in the production or testing of biological or in health camps.
https://www.slideshare.net/SonamAggarwal7/biomedical-waste-management-and-biohazards-by-dr-sonam-aggarwal
types of biomedical waste, segregation, classification, sources, hazards and treatment like incineration, inertization, chemical treatment, biomedical waste rule
The waste produced in the course of health care activities carries a higher potential for infection & injury than any other type of waste.
Inadequate & inappropriate handling of health care waste may have serious public health consequences and it has a very significant impact on environment.
Appropriate management of health care waste is thus a crucial component of environmental health protection and it should become an integral feature of health care services.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
2. DEFENITION
• As per Bio-Medical Waste(Management and
Handling ) Rules 1998 of India
• “Bio-medical waste” means any waste which
is generated during the diagnosis, treatment
or immunisation of human beings or animals,
or in research activities thereto or in the
production or testing of biologicals, and
including categories as mentioned in table
3. • In addition, it includes the waste originating
from minor or scattered sources such as that
produced in the course of health care
undertaken in the home (dialysis, insulin
injections, etc.).
4. Dangers of improper Management of Bio-Medical
Waste
• Public health hazard-can cause a number of
disease.
• Children and rag pickers are particularly at risk.
• Inappropriate treatment & disposal-
environmental pollution .
• Uncontrolled incineration-air pollution.
• Dumping in drains, tanks ,along the river bed-
water pollution.
• Unscientific land filling-soil pollution.
5. Dangers of improper Management of Bio-
Medical Waste
• Mixed with general waste - whole of waste turn
to infectious waste.
• Sharps --needle stick injuries, cuts, and
infections.
• Needles and syringes which are not mutilated
or destroyed -circulated back through traders
and destitute.
6. Dangers of improper Management of
Bio-Medical Waste
• The dumping of untreated bio-medical waste -
epidemics & increased incidence of
communicable diseases.
• Vector population like cats, rats, mosquitoes,
flies and stray dogs increases.
7. SOURCES
• Govt & private hospitals
• Nursing home
• Physicians clinics
• Dentists clinics
• Dispensaries
• PHCs
• Medical research & training establishments
• Mortuaries
• Blood banks
• Labs etc
8. HEALTH CARE WASTE
GENERATION
• 80% general health care waste –dealt as
normal domestic & urban waste management
system
• 15%-pathological & infectious waste
• 3%-chemical & pharmacological waste
• 1%-sharps waste
• <1%-special waste radioactive ,cytotoxic
waste, broken thermometers, used batteries
etc
9. • WHO classified medical waste into eight
categories:
1. General waste
2. Pathological waste
3. Radioactive waste
4. Chemical waste
5. Infectious waste and potentially infectious waste
6. Sharps
7. Pharmaceutical waste
8. Pressurised containers
10. HEALTH HAZARDS OF HEALTH
CARE WASTE
Exposure to health care waste results in disease
or injury due to:
1. Contain infectious agents
2. Contain toxic or hazardous agents
3. Contain sharps
4. Is genotoxic
5. Is radioactive
11. Main group at risk include:
• Med doctors, nurses,
health care auxillaries &
hospital maintenance
personnel
• Patients in heath care
establishments
• Visitors to health care
establishments
• Workers in support service
allied to health care
• Workers in waste disposal
12. WHO (in 2000) estimated that, injections with
contaminated syringes caused:
• 21 million hepatitis B virus (HBV) infections
(32% of all new infections);
• Two million hepatitis C virus (HCV) infections
(40% of all new infections);
• 2,60 ,000 HIV infections (5% of all new
infections).
13. Epidemiological studies indicate that
• a person who experiences one needle-stick
injury from a needle used on an infected source
patient has risks of
30%, 1.8%, and 0.3% respectively to become
infected with HBV, HCV and HIV.
14. Approximately 3 million HCWs experience
percutaneous exposure to blood borne viruses
(BBVs) each year.
This results in an estimated 16,000 HCV, 66,000
HBV and 200-5000 HIV infections annually.
( Source: Needle stick injuries in a tertiary care hospital by S T
Jayanth et al , Indian Journal of Medical Microbiology, year 2009
, Vol. 27, Issue 1, page 44-47)
15. • WHO assessment (2002 ) conducted in 22
developing countries :- showed that
The proportion of healthcare facilities that do
not use proper waste disposal methods
ranges from 18% to 64%.
(WHO-Health-care waste management,To reduce the burden of disease,
health-care waste needs sound management, including alternatives to
incineration,Fact sheet N°281,October 2011 )
16. Regulations on Bio-medical Waste
Management
• Biomedical Waste (Handling and Management)
Rules—
• In 1998, by the MoEF
• Based on the principle of segregation of
communal waste from BMW, followed by
containment, treatment, and disposal of BMWs
in different categories.
• The rules were amended twice in 2000, primarily
to address administrative matters.
17. State Strategies and Activities Related
to Health Care Waste Management
• The responsibility was delegated to individual
states and territories, with
• State Pollution Control Boards (SPCBs) in states .
• Pollution Control Committees in territories
designated as the authorities.
18. Schedules..
• Schedule 1- category wise treatment and disposal
methodology .
• Schedule II-color coding &type of container for
disposal.
• Schedule III- Label for Bio-Medical Waste
Containers/ Bags.
• Schedule IV- Describes the type of waste where it is
generated and to where it is being transferred.
• Schedule V - Standards for incinerators, autoclave,
liquid waste, microwave and deep burial.
• Schedule VI- Schedule For Waste Treatment Facilities.
19. Forms
• Form I:-Application For Authorisation /Renewal Of
Authorisation
• Form II:-Annual report (To be submitted to the
prescribed authority by 31 January every year)
• Form III:- Accident Reporting
• Form IV:-Authorisation for operating a facility for
collection, reception, treatment, storage transport
and disposal of biomedical wastes.
• Form V:- Application for filing appeal against order
passed by the prescribed authority at district level or
regional office of the PCB acting as prescribed
authority or the State/Union Territory level authority
21. INCINERATION
• High temp dry oxidation process
which reduces org & combustible
waste to inorganic incombustible
matter.
• Significant reduction in waste
volume and weight.
• Selected for wastes that cannot be recycled,
reused or disposed off
22. Characteristics of suitable waste:
1. Low heating volume-
• >2000kcal/kg – single chamber
• >3500kcal/kg –pyrolytic double chamber
2. Combustible matter > 60%
3. Non combustible solids < 5%
4. Non comustible fines <20 %
5. Moisture content <30%
23. Not to be incinerated:
1. Pressurised gas containers
2. Large amount of reactive chemical waste
3.Silver salts and photographic or radiographic
waste
4.Halogeated plastics such as PVC
5.High Hg or Cadmium containing-broken
thermometers, used batteries
6. Sealed ampules or ampules containing heavy
metals
24. TYPES OF INCINERATORS
a) Double chamber pyrolytic incinerators-to
burn infectious waste
b) Single chamber furnaces-used only if
pyrolytic incinerators are unaffordable
c) Rotary kilns operating at high temperature-
causes decomposition of genotoxic
substances & heat resistant chemicals
25. CHEMICAL DISINFECTION
• Disinfection rather than sterilisation
• Treating liquid waste-blood, urine, stools or
hospital sewage
• Solid waste with certain limitation
26. WET & DRY THERMAL TREATMENT
WET THERMAL TREATMENT/STEAM DISINFECTION:
• Exposure of waste to high temperature, high
pressure steam similar to autoclaving
• Inappropriate for anatomical waste, animal
carcass, chem & pharm waste
27. SCREW-FEED TECHNOLOGY:
• Non burn dry thermal
disinfection
• Heated in a rotating auger
• Waste volume reduced by
80% volume & 20-35 % wt
• Suitable for inf waste
and sharps
• Cannot be used for pathological
, cytotoxic or radioactive waste
28. MICROWAVE IRRADIATION
• Works at frequency of about 2450 MHz &
wave length of 12.24nm
• Water contained is rapidly heated & inf
content destroyed
29. LAND DISPOSAL
MUNICIPAL DISPOSAL SITES:
• If there is genuine lack of means to treat
waste before disposal
• Two types-
1. Open dumps
2. Sanitary land fills
• Health care wastes should not be disposed
on or around open dumps
30. SANITARY LAND FILLS:
ADVANTAGES:
• Geological isolation
• Appropriate engineering
preparations
• Staff present on site
to control operations
• Organised deposits
• Daily coverage of waste
31. INERTIZATION
• Mixing waste with cement & other substances
before disposal to minimise the risk of toxic
substance in the waste migrating into surface
waster or ground water
32. • Typical proportion is:
• 65 %- pharmaceutical waste
• 15 % - lime
• 15 % - cement
• 5 % - water
• Homogenous mass is produced on site and
cubes or pellets are transported to suitable
storage site
33. • The final choice of treatment should be made
on the basis of factors, many of which depend
on local conditions.
34. BIO-MEDICAL WASTE
MANAGEMENT IN INDIA
• Bio-Medical Waste (Management & handling)
Rule 1998, by Ministry Of Environment and
Forests, Govt of India came in force on 28th July
1998
• Rule applies to those who generate, collect,
receive, store, dispose, treat or handle
biomedical waste in any manner
• Waste should be segregated into containers or
bags at the point of generation of waste.
35. Schedule 1: Categories of Bio-Medical Waste
Waste
Category
Waste Category Type Treatment and
Disposal
Option+
Category No. 1 Human Anatomical Waste (body parts, organs,
human tissues etc.).
Incineration /
deep burial
Category No. 2 Animal Waste (animal tissues, organs, body
parts, carcasses, bleeding parts, fluid, blood
and experimental animals used in research,
waste generated by veterinary hospitals,
colleges, discharge from hospitals, animal
houses).
Incineration /
deep burial
Category No. 3 Microbiology & Biotechnology Waste (Wastes
from laboratory cultures, stocks or micro-
organisms live or vaccines, human and animal
cell culture used in research and infectious
agents from research and industrial
laboratories, wastes from production of
biologicals, toxins, dishes and devices used for
transfer of cultures).
Local
autoclaving/
micro waving /
incineration
36. Category No. 4 Waste Sharps (needles,
syringes, scalpels, blade,
glass, etc. that may cause
puncture and cuts. This
includes both used and
unused sharps).
Disinfection
(chemical treatment
/ autoclaving /
micro waving and
mutilation /
shredding
Category No. 5 Discarded Medicines and
Cytotoxic drugs (Waste
comprising of outdated,
contaminated and discarded
medicines).
Incineration /
destruction and
drugs disposal in
secured landfills
Category No. 6 Soiled Waste (items
contaminated with blood,
and body fluids including
cotton, dressings, soiled
plaster casts, lines, bedding,
other material contaminated
with blood).
Local autoclaving /
micro waving /
incineration
Category No. 7 Solid Waste (Waste
generated from disposal
items other than the sharps
such a tubings, catheters,
intravenous sets etc.).
Disinfection by chemical
treatment /autoclaving /
micro waving and
mutilation/
shredding
37. Category No. 8 Liquid Waste (Waste
generated from
laboratory and
washing, cleaning,
housekeeping and
disinfecting activities).
Disinfection by
chemical treatment
and discharge
into drains
Category No. 9 Incineration Ash (Ash
from incineration of
any bio-medical
waste).
Disposal in
municipal landfill
CategoryNo.10 Chemical Waste
(Chemicals used in
production of
biologicals, chemicals
used in disinfection, as
insecticides, etc.).
Disinfection by
chemical treatment
and discharge into
drains for
liquids and secured
land fill for solids
38.
39.
40.
41. BIOMEDICAL WASTE MANAGEMENT BY IMAGE
• Indian Medical Association Kerala State Branch
established a Common Biomedical Waste
Treatment and Disposal Facility at Palakkad.
• Established on 14thDecember 2003.
42. IMAGE..
• The affiliation fee is Rs. 1000/- per bed.
• The minimum affiliation fee for clinics,
laboratory, and diagnosis centre, dental clinics
with two chairs -Rs. 5000/-
• Government hospitals have been exempted
from paying affiliation fee.
43. IMAGE…
• Charge of BMW management:-
Govt. hospitals Rs.2.75/bed/day
Private hospitals Rs.3.50/bed/day
• IMAGE serves in all the 14 districts of the state.
• More than 2500 health care establishments are
affiliated to IMAGE.
• Total bed strength of about 65000.
44. IMAGE…
• IMAGE handles more than half of the biomedical
waste generated in Kerala.
• IMAGE consists of a common treatment and
disposal facility.
• The treatment facilities consist of 3 incinerators,
2 autoclaves, 1 shredder, sharp pits, facility for
storage of incineration ash, waste water
treatment plant, etc.
45. IMAGE…
• KEIL (Kerala Environmental Infrastructure
Limited) ,Ernakulum :- collects and transports
all incineration ash and waste water treatment
plant sludge from IMAGE.
• This model is unique to Kerala and has
propelled the state ahead of other states.
46. Services by the IMAGE
• Training the staff of the institutions for scientific
segregation of biomedical waste.
• Provision to make available colour coded bags
and containers with emblem.
• Daily collection of segregated and contained
biomedical waste from institutions.
47. Services(IMAGE)
• Safe disposal of the biomedical waste in the
plant as per the rules.
• To make available monthly statement regarding
the quantity of biomedical waste collected and
disposed on behalf of the institutions.
• Facilitate to obtain Authorization from the State
Pollution Control Board.
49. India
• In South region, 35 Common Biomedical
Waste Treatment Facilities (CBWTF) mainly by
private agencies
• Andhra Pradesh -14 nos
• Tamilnadu -11 nos
• Karnataka -9 nos
• Kerala -1no.
50. Kerala
• {Source-Central Pollution Control Board:-Annual Report
Information on Bio-medical Waste Management for the year
2010 (as submitted by SPCBs)}
• Kerala has the highest number (about 27%) of
health care institutions in India.
• Total no. of HCF-3168
• Total bed strength of hospitals in Kerala-1,13,530
• 43,273 are in the Government sector
• 2,740 in the co-operative sector and
• 67,517 in the private sector.
51. Kerala
• No of CBWTF-1
• No of HCF utilising CBWTF-1175
• No of HCF having treatment and disposal
facilities- 352
• No. of HCF applied for Authorisation-1384
• No. of HCF granted authorisation-694
52. Kerala..
• Total Quantity of BMW generated (kg/day) (Approx)-
34679
• Total Quantity of BMW treated (kg/day) (Approx)-30565
• Waste water generated 450L/bed/days
• No. of Healthcare Facilities violated BMW Rules-644
• Total No. of Show cause notices/Directions issued to
defaulter HCFs-281
53. Medical College Hospital, Kozhikode
• Only one incinerator in MCH
• One incinerator in MCH –not working
• IMCH- all infectious waste are taken by IMAGE
• IMAGE charges Rs.4.50/bed/day
• No other waste treatment facility.
MCH
• All waste including human anatomical waste,
plastics including packing materials, tubings etc
are incinerated.
• No proper segregation of waste.
54. MCH
• Pollution control devices are fitted to the
incinerator-but damaged &poorly maintained.
• Incinerator releasing black fumes directly to
operation theaters.
• Needles, broken ampoules etc. are buried in
pit.
• Personal protective measures are inadequate.